Nuvalent filed a new drug application for an experimental non-small cell lung cancer treatment with the Food and Drug Administration.

Prescription Drug User Fee Act (PDUFA) target action date set for June 29, 2026If approved, ZORYVE cream 0.3% would be the first and only topical ...

Nuvalent (NUVL) announced the FDA has accepted for filing its New Drug Application, or NDA, for zidesamtinib, an investigational ROS1-selective ...

The program, called YesRx, takes in donations and dispenses oral cancer and supportive drugs to those in need, giving away ...

Experimental pill versions of GLP-1 weight loss drugs by Novo Nordisk and Eli Lilly will receive FDA priority review. Read ...

Lower prices for 15 drugs, including Ozempic and Wegovy, are expected to be announced by the end of the month. The price ...

Operated by the federal government, TrumpRx aims to reduce the amount that Americans — including Medicaid patients — pay for ...

Teaming up with the Healey & AMG Center, Inflammasome will advance its oral ALS drug kamuvudine-9, known as K9, into early clinical testing.

It's hard to hide when you have weekly meetings in front of a judge, parole officer and drug counselor. It's difficult to slip, unnoticed, through syringe-filled cracks when subjected to twice-a-week ...

Oregon Health & Science University leaders say a federal drug discount pilot set to begin next year could create a ...